Article Text
LETTER
RSV and bronchiolitis
Statistics from Altmetric.com
In the study by Bala and colleagues,1 it seems that interpretations on cost effectiveness of palivizumab are made based on the number of admissions for bronchiolitis alone.
We conducted an epidemiological study to determine the importance of respiratory syncytial virus (RSV) in the region on 412 …